Max J. M. Silvis

724 total citations
17 papers, 399 citations indexed

About

Max J. M. Silvis is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Max J. M. Silvis has authored 17 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Cardiology and Cardiovascular Medicine and 6 papers in Surgery. Recurrent topics in Max J. M. Silvis's work include Inflammasome and immune disorders (6 papers), Cardiovascular Disease and Adiposity (5 papers) and Cardiac Imaging and Diagnostics (4 papers). Max J. M. Silvis is often cited by papers focused on Inflammasome and immune disorders (6 papers), Cardiovascular Disease and Adiposity (5 papers) and Cardiac Imaging and Diagnostics (4 papers). Max J. M. Silvis collaborates with scholars based in Netherlands, United States and Belgium. Max J. M. Silvis's co-authors include Dominique P.V. de Kleijn, Leo Timmers, Lena Bosch, Gerardus P. J. van Hout, Mirthe Dekker, Aernoud T.L. Fiolet, Arend Mosterd, Saskia C.A. de Jager, Pieter A. Doevendans and Joost P. G. Sluijter and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Max J. M. Silvis

17 papers receiving 395 citations

Peers

Countries citing papers authored by Max J. M. Silvis

Since Specialization

Citations

This map shows the geographic impact of Max J. M. Silvis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max J. M. Silvis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max J. M. Silvis more than expected).

Fields of papers citing papers by Max J. M. Silvis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max J. M. Silvis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max J. M. Silvis. The network helps show where Max J. M. Silvis may publish in the future.

Co-authorship network of co-authors of Max J. M. Silvis

This figure shows the co-authorship network connecting the top 25 collaborators of Max J. M. Silvis. A scholar is included among the top collaborators of Max J. M. Silvis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max J. M. Silvis. Max J. M. Silvis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	The Effect of Years-Long Exposure to Low-Dose Colchicine on Renal and Liver Function and Blood Creatine Kinase Levels: Safety Insights from the Low-Dose Colchicine 2 (LoDoCo2) Trial 2022 ·Clinical Drug Investigation ·(unknown), (unknown), Max J. M. Silvis, J. Los, Aernoud T.L. Fiolet, Tjerk S.J. Opstal, Arend Mosterd, John W. Eikelboom, Stefan M. Nidorf, Charley Budgeon, Elizabeth M. Byrnes, Willem A. Bax, Jan G.P. Tijssen, Dominique P.V. de Kleijn, Peter L. Thompson, (unknown), Jan H. Cornel	13
2	End-of-trial inflammatory biomarkers, lipid levels, creatine kinase and markers of renal and liver function in the LoDoCo2 trial 2022 ·European Heart Journal ·(unknown), (unknown), Max J. M. Silvis, J. Los, Aernoud T.L. Fiolet, Tjerk S.J. Opstal, Arend Mosterd, John W. Eikelboom, Stefan M. Nidorf, (unknown), Jan G.P. Tijssen, Dominique P.V. de Kleijn, Peter L. Thompson, Saloua El Messaoudi, Jan H. Cornel	1
3	NLRP3-Inflammasome Inhibition with IZD334 Does Not Reduce Cardiac Damage in a Pig Model of Myocardial Infarction 2022 ·Biomedicines ·Max J. M. Silvis, (unknown), Leo Timmers, Fatih Arslan, Saskia C.A. de Jager, Joost P. G. Sluijter, Arend Mosterd, Dominique P.V. de Kleijn, Lena Bosch, Gerardus P. J. van Hout	5
4	Neutral Effects of Combined Treatment With GLP-1R Agonist Exenatide and MR Antagonist Potassium Canrenoate on Cardiac Function in Porcine and Murine Chronic Heart Failure Models 2021 ·Frontiers in Pharmacology ·(unknown), (unknown), Max J. M. Silvis, (unknown), (unknown), (unknown), Maike A. D. Brans, Evelyn Velema, Joost P. G. Sluijter, Imo E. Hoefer, Dominique P.V. de Kleijn, Leo Timmers, Saskia C.A. de Jager	5
5	Targeting residual inflammatory risk in coronary disease: to catch a monkey by its tail 2021 ·Netherlands Heart Journal ·Aernoud T.L. Fiolet, Tjerk S.J. Opstal, Max J. M. Silvis, Jan H. Cornel, Arend Mosterd	5
6	Experimental parameters and infarct size in closed chest pig LAD ischemia reperfusion models; lessons learned 2021 ·BMC Cardiovascular Disorders ·Max J. M. Silvis, Gerardus P. J. van Hout, Aernoud T.L. Fiolet, Mirthe Dekker, Lena Bosch, (unknown), (unknown), (unknown), Leo Timmers, Dominique P.V. de Kleijn	8
7	Efficacy of coronary sinus Reducer in patients with refractory angina and diabetes mellitus 2021 ·Heart and Vessels ·Giovanni Maria Vescovo, Carlo Zivelonghi, Pierfrancesco Agostoni, Mirthe Dekker, Max J. M. Silvis, Geert E. Leenders, J.P. van Kuijk, Leo Timmers, Pieter R. Stella, Shmuel Banai, Stefan Verheye	4
8	High levels of osteoprotegerin are associated with coronary artery calcification in patients suspected of a chronic coronary syndrome 2021 ·Scientific Reports ·Mirthe Dekker, Farahnaz Waissi, Max J. M. Silvis, (unknown), Arjan H. Schoneveld, Robbert J. de Winter, Ivana Išgum, Nikolas Leßmann, Birgitta K. Velthuis, Gerard Pasterkamp, Arend Mosterd, Leo Timmers, Dominique P.V. de Kleijn	12
9	Colchicine reduces extracellular vesicle NLRP3 inflammasome protein levels in chronic coronary disease: A LoDoCo2 biomarker substudy 2021 ·Atherosclerosis ·Max J. M. Silvis, Aernoud T.L. Fiolet, Tjerk S.J. Opstal, Mirthe Dekker, (unknown), (unknown), Michiel Duyvendak, Salem H.K. The, Leo Timmers, Willem A. Bax, Arend Mosterd, Jan H. Cornel, Dominique P.V. de Kleijn	44
10	Extracellular Vesicle cystatin c is associated with unstable angina in troponin negative patients with acute chest pain 2020 ·PLoS ONE ·Mirthe Dekker, Farahnaz Waissi, (unknown), Max J. M. Silvis, Nathalie Timmerman, Arjan H. Schoneveld, Diederick E. Grobbee, Robbert J. de Winter, Arend Mosterd, Leo Timmers, Dominique P.V. de Kleijn	11
11	Short-term effect of low-dose colchicine on inflammatory biomarkers, lipids, blood count and renal function in chronic coronary artery disease and elevated high-sensitivity C-reactive protein 2020 ·PLoS ONE ·Aernoud T.L. Fiolet, Max J. M. Silvis, Tjerk S.J. Opstal, Willem A. Bax, F.A.L. van der Horst, Arend Mosterd, Dominique P.V. de Kleijn, Jan H. Cornel	35
12	Plasma extracellular vesicle proteins are associated with stress-induced myocardial ischemia in women presenting with chest pain 2020 ·Scientific Reports ·Mirthe Dekker, Farahnaz Waissi, (unknown), Max J. M. Silvis, Nathalie Timmerman, Ingrid E.M. Bank, Joan Walter, Christian Mueller, Arjan H. Schoneveld, Raymond M. Schiffelers, Gerard Pasterkamp, Diederick E. Grobbee, Robbert J. de Winter, Arend Mosterd, Dominique P.V. de Kleijn, Leo Timmers	18
13	Damage-Associated Molecular Patterns in Myocardial Infarction and Heart Transplantation: The Road to Translational Success 2020 ·Frontiers in Immunology ·Max J. M. Silvis, (unknown), (unknown), Mudit Mishra, Niels P. van der Kaaij, Pieter A. Doevendans, Joost P. G. Sluijter, Dominique P.V. de Kleijn, Saskia C.A. de Jager, Lena Bosch, Gerardus P. J. van Hout	109
14	The Coronary Sinus Reducer; 5-year Dutch experience 2020 ·Netherlands Heart Journal ·Max J. M. Silvis, Mirthe Dekker, Carlo Zivelonghi, Piergiuseppe Agostoni, (unknown), Pieter A. Doevendans, Dominique P.V. de Kleijn, J.P. van Kuijk, Geert E. Leenders, Leo Timmers	14
15	Efficacy of Coronary Sinus Reducer in Patients With Non-revascularized Chronic Total Occlusions 2020 ·The American Journal of Cardiology ·Carlo Zivelonghi, Stefan Verheye, Leo Timmers, J.P. van Kuijk, Francesco Giannini, Mirthe Dekker, Max J. M. Silvis, Masieh Abawi, Geert E. Leenders, (unknown), (unknown), Alessandro Beneduce, Giovanni Benfari, Pieter R. Stella, José P.S. Henriques, Shmuel Banai, Pierfrancesco Agostoni	24
16	Immunomodulation of the NLRP3 Inflammasome in Atherosclerosis, Coronary Artery Disease, and Acute Myocardial Infarction 2020 ·Journal of Cardiovascular Translational Research ·Max J. M. Silvis, (unknown), Aernoud T.L. Fiolet, Mirthe Dekker, Lena Bosch, Gerardus P. J. van Hout, Leo Timmers, Dominique P.V. de Kleijn	84
17	Extracellular Vesicles in Diagnosing Chronic Coronary Syndromes the Bumpy Road to Clinical Implementation 2020 ·International Journal of Molecular Sciences ·Mirthe Dekker, Farahnaz Waissi, Nathalie Timmerman, Max J. M. Silvis, Leo Timmers, Dominique P.V. de Kleijn	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact